Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Serge R. Martinod | M | - |
TNG Pharmaceuticals, Inc.
 TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | 12 years |
| Phoebe Wood | F | 70 |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| Dale J. Boden | M | 67 |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| Kent R. van Kampen | M | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
| Butch L. Mercer | M | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jennifer Corbin | F | - |
TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. BiotechnologyHealth Technology TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded by Larry Horn and Jennifer Corbin in 2011 and is headquartered in Louisville, KY. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Larry Horn
- Personal Network
